Unicycive Therapeutics News

Unicycive Therapeutics | 8-K: Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update

04:29

Unicycive Therapeutics | DEFA14A: Others

May 9 04:11

Unicycive Therapeutics | DEF 14A: Definitive information statements

Apr 27 05:15

Unicycive Therapeutics | DEFA14A: Others

Apr 27 05:15

Unicycive Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 17 04:13

Unicycive Therapeutics | 8-K: Current report

Mar 30 01:28

Unicycive Therapeutics | 8-K: Current report

Mar 15 04:31

Unicycive Therapeutics | 8-K: Current report

Mar 15 04:05

Unicycive Therapeutics | 8-K: Current report

Feb 22 05:12

Unicycive Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 9, 2023 05:36

Unicycive Therapeutics | 8-K: Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update

Nov 15, 2023 05:42

Unicycive Therapeutics | 8-K: Current report

Oct 23, 2023 23:12

Unicycive Therapeutics | 8-K: Current report

Sep 26, 2023 04:05

Unicycive Therapeutics | 8-K: Current report

Sep 6, 2023 21:16

Unicycive Therapeutics | 8-K: Current report

Sep 1, 2023 04:16

Unicycive Therapeutics | 8-K: Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update

Aug 15, 2023 09:19

Unicycive Therapeutics | 8-K: Current report

Aug 1, 2023 04:15

Unicycive Therapeutics | 8-K: Current report

Jul 26, 2023 18:05

Unicycive Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jul 13, 2023 07:49

Unicycive Therapeutics | 8-K: Current report

Jun 30, 2023 05:50